SMALL INTESTINE ADENOCARCINOMA

This adverse event was reported 179 times

These drugs are most commonly taken by patients reporting SMALL INTESTINE ADENOCARCINOMA:

# Drug Count
0 ADALIMUMAB 36
1 INFLIXIMAB 26
2 PREDNISONE 22
3 AZATHIOPRINE 20
4 ADALIMUMAB-AATY 16
5 ADALIMUMAB-ADAZ 16
6 ADALIMUMAB-FKJP 16
7 USTEKINUMAB 16
8 MYCOPHENOLATE MOFETIL 14
9 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 14
See all common drugs associated with SMALL INTESTINE ADENOCARCINOMA

SMALL INTESTINE ADENOCARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MEPIVACAINE HYDROCHLORIDE 9 0.0078
1 PEGFILGRASTIM-JMDB 2 0.0044
2 PANTHENOL 1 0.0034
3 BEPOTASTINE BESILATE 2 0.0031
4 VERAPAMIL HYDROCHLORIDE 9 0.0021
5 FOSNETUPITANT AND PALONOSETRON 2 0.0017
6 NETUPITANT AND PALONOSETRON 2 0.0017
7 PIROXICAM 9 0.0014
8 PLERIXAFOR 1 0.0007
9 TALIMOGENE LAHERPAREPVEC 1 0.0006
See all drugs enriched for association with SMALL INTESTINE ADENOCARCINOMA